Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma
To evaluate whether if ultrasonography (US)-based radiomics enables prediction of the presence of BRAFV600E mutations among patients diagnosed as papillary thyroid carcninoma (PTC). From December 2015 to May 2017, 527 patients who had been treated surgically for PTC were included (training: 387, val...
Gespeichert in:
Veröffentlicht in: | PloS one 2020, Vol.15 (2), p.e0228968-e0228968 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0228968 |
---|---|
container_issue | 2 |
container_start_page | e0228968 |
container_title | PloS one |
container_volume | 15 |
creator | Yoon, Jung Hyun Han, Kyunghwa Lee, Eunjung Lee, Jandee Kim, Eun-Kyung Moon, Hee Jung Park, Vivian Youngjean Nam, Kee Hyun Kwak, Jin Young |
description | To evaluate whether if ultrasonography (US)-based radiomics enables prediction of the presence of BRAFV600E mutations among patients diagnosed as papillary thyroid carcninoma (PTC).
From December 2015 to May 2017, 527 patients who had been treated surgically for PTC were included (training: 387, validation: 140). All patients had BRAFV600E mutation analysis performed on surgical specimen. Feature extraction was performed using preoperative US images of the 527 patients (mean size of PTC: 16.4mm±7.9, range, 10-85 mm). A Radiomics Score was generated by using the least absolute shrinkage and selection operator (LASSO) regression model. Univariable/multivariable logistic regression analysis was performed to evaluate the factors including Radiomics Score in predicting BRAFV600E mutation. Subgroup analysis including conventional PTC |
doi_str_mv | 10.1371/journal.pone.0228968 |
format | Article |
fullrecord | <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_2354744429</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_df2b74f0c33e454085d48b75bf33907a</doaj_id><sourcerecordid>2354744429</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3718-60a08a636ba44ea2a5d0ef72e5ffab9188bb1f8140269127a2d7b7344cbe67b93</originalsourceid><addsrcrecordid>eNptkstu1DAUhiMEoqXwBggisWEzg2-xHRaVhqqFSpWQKmBr2Y499Sixg50gzSvxlDhNOkwRq3Nk__93LjpF8RqCNcQMftiFMXrZrvvgzRogxGvKnxSnsMZoRRHAT4_yk-JFSjsAKswpfV6cYJRTysBp8ftWNi50TqfS-bKPpnF6cH5bduMgBxd8mXIcU2lDLIe7fQyuKbX02sSP5WYytK5zXsZ9Fo7NvhzT5I4HqjXZHs0MOOJ_ut1c_aAAXB4qzR3I3rXthPtbLGrnQydfFs-sbJN5tcSz4vvV5beLL6ubr5-vLzY3K53XwlcUSMAlxVRJQoxEsmqAsQyZylqpasi5UtBySACiNURMooYphgnRylCmanxWvJ25fRuSWNacBMIVYYQQNCmuZ0UT5E700XW5YRGkE_cPIW6FjIPTrRGNRYoRCzTGhlQE8KohXLFKWYxrwGRmnS_VRtWZRhs_RNk-gj7-8e5ObMMvwQDkANAMeL8AYvg5mjSIziVt8hK9CeN931VdUViDLH33j_T_05FZpWNIKRp7aAYCMZ3eg0tMpyeW08u2N8eDHEwPt4b_AFhR2yE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2354744429</pqid></control><display><type>article</type><title>Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Yoon, Jung Hyun ; Han, Kyunghwa ; Lee, Eunjung ; Lee, Jandee ; Kim, Eun-Kyung ; Moon, Hee Jung ; Park, Vivian Youngjean ; Nam, Kee Hyun ; Kwak, Jin Young</creator><creatorcontrib>Yoon, Jung Hyun ; Han, Kyunghwa ; Lee, Eunjung ; Lee, Jandee ; Kim, Eun-Kyung ; Moon, Hee Jung ; Park, Vivian Youngjean ; Nam, Kee Hyun ; Kwak, Jin Young</creatorcontrib><description>To evaluate whether if ultrasonography (US)-based radiomics enables prediction of the presence of BRAFV600E mutations among patients diagnosed as papillary thyroid carcninoma (PTC).
From December 2015 to May 2017, 527 patients who had been treated surgically for PTC were included (training: 387, validation: 140). All patients had BRAFV600E mutation analysis performed on surgical specimen. Feature extraction was performed using preoperative US images of the 527 patients (mean size of PTC: 16.4mm±7.9, range, 10-85 mm). A Radiomics Score was generated by using the least absolute shrinkage and selection operator (LASSO) regression model. Univariable/multivariable logistic regression analysis was performed to evaluate the factors including Radiomics Score in predicting BRAFV600E mutation. Subgroup analysis including conventional PTC <20-mm (n = 389) was performed (training: 280, validation: 109).
Of the 527 patients diagnosed with PTC, 428 (81.2%) were positive and 99 (18.8%) were negative for BRAFV600E mutation. In both total 527 cancers and 389 conventional PTC<20-mm, Radiomics Score was the single factor showing significant association to the presence of BRAFV600E mutation on multivariable analysis (all P<0.05). C-statistics for the validation set in the total cancers and the conventional PTCs<20-mm were lower than that of the training set: 0.629 (95% CI: 0.516-0.742) to 0.718 (95% CI: 0.650-0.786), and 0.567 (95% CI: 0.434-0.699) to 0.729 (95% CI: 0.632-0.826), respectively.
Radiomics features extracted from US has limited value as a non-invasive biomarker for predicting the presence of BRAFV600E mutation status of PTC regardless of size.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0228968</identifier><identifier>PMID: 32053670</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Age ; Biology and Life Sciences ; Biomarkers ; Cancer ; Feature extraction ; Hospitals ; Lymphatic system ; Medical diagnosis ; Medical prognosis ; Medical schools ; Medicine ; Medicine and Health Sciences ; Metastasis ; Mortality ; Mutation ; Papillary thyroid carcinoma ; Patients ; Physical Sciences ; Radiology ; Radiomics ; Regression analysis ; Regression models ; Research and Analysis Methods ; Statistical analysis ; Subgroups ; Surgery ; Thyroid ; Thyroid cancer ; Training ; Ultrasound</subject><ispartof>PloS one, 2020, Vol.15 (2), p.e0228968-e0228968</ispartof><rights>2020 Yoon et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 Yoon et al 2020 Yoon et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3718-60a08a636ba44ea2a5d0ef72e5ffab9188bb1f8140269127a2d7b7344cbe67b93</citedby><cites>FETCH-LOGICAL-c3718-60a08a636ba44ea2a5d0ef72e5ffab9188bb1f8140269127a2d7b7344cbe67b93</cites><orcidid>0000-0002-6212-1495</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018006/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018006/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,4010,23845,27900,27901,27902,53766,53768,79569,79570</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32053670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yoon, Jung Hyun</creatorcontrib><creatorcontrib>Han, Kyunghwa</creatorcontrib><creatorcontrib>Lee, Eunjung</creatorcontrib><creatorcontrib>Lee, Jandee</creatorcontrib><creatorcontrib>Kim, Eun-Kyung</creatorcontrib><creatorcontrib>Moon, Hee Jung</creatorcontrib><creatorcontrib>Park, Vivian Youngjean</creatorcontrib><creatorcontrib>Nam, Kee Hyun</creatorcontrib><creatorcontrib>Kwak, Jin Young</creatorcontrib><title>Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>To evaluate whether if ultrasonography (US)-based radiomics enables prediction of the presence of BRAFV600E mutations among patients diagnosed as papillary thyroid carcninoma (PTC).
From December 2015 to May 2017, 527 patients who had been treated surgically for PTC were included (training: 387, validation: 140). All patients had BRAFV600E mutation analysis performed on surgical specimen. Feature extraction was performed using preoperative US images of the 527 patients (mean size of PTC: 16.4mm±7.9, range, 10-85 mm). A Radiomics Score was generated by using the least absolute shrinkage and selection operator (LASSO) regression model. Univariable/multivariable logistic regression analysis was performed to evaluate the factors including Radiomics Score in predicting BRAFV600E mutation. Subgroup analysis including conventional PTC <20-mm (n = 389) was performed (training: 280, validation: 109).
Of the 527 patients diagnosed with PTC, 428 (81.2%) were positive and 99 (18.8%) were negative for BRAFV600E mutation. In both total 527 cancers and 389 conventional PTC<20-mm, Radiomics Score was the single factor showing significant association to the presence of BRAFV600E mutation on multivariable analysis (all P<0.05). C-statistics for the validation set in the total cancers and the conventional PTCs<20-mm were lower than that of the training set: 0.629 (95% CI: 0.516-0.742) to 0.718 (95% CI: 0.650-0.786), and 0.567 (95% CI: 0.434-0.699) to 0.729 (95% CI: 0.632-0.826), respectively.
Radiomics features extracted from US has limited value as a non-invasive biomarker for predicting the presence of BRAFV600E mutation status of PTC regardless of size.</description><subject>Age</subject><subject>Biology and Life Sciences</subject><subject>Biomarkers</subject><subject>Cancer</subject><subject>Feature extraction</subject><subject>Hospitals</subject><subject>Lymphatic system</subject><subject>Medical diagnosis</subject><subject>Medical prognosis</subject><subject>Medical schools</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Metastasis</subject><subject>Mortality</subject><subject>Mutation</subject><subject>Papillary thyroid carcinoma</subject><subject>Patients</subject><subject>Physical Sciences</subject><subject>Radiology</subject><subject>Radiomics</subject><subject>Regression analysis</subject><subject>Regression models</subject><subject>Research and Analysis Methods</subject><subject>Statistical analysis</subject><subject>Subgroups</subject><subject>Surgery</subject><subject>Thyroid</subject><subject>Thyroid cancer</subject><subject>Training</subject><subject>Ultrasound</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNptkstu1DAUhiMEoqXwBggisWEzg2-xHRaVhqqFSpWQKmBr2Y499Sixg50gzSvxlDhNOkwRq3Nk__93LjpF8RqCNcQMftiFMXrZrvvgzRogxGvKnxSnsMZoRRHAT4_yk-JFSjsAKswpfV6cYJRTysBp8ftWNi50TqfS-bKPpnF6cH5bduMgBxd8mXIcU2lDLIe7fQyuKbX02sSP5WYytK5zXsZ9Fo7NvhzT5I4HqjXZHs0MOOJ_ut1c_aAAXB4qzR3I3rXthPtbLGrnQydfFs-sbJN5tcSz4vvV5beLL6ubr5-vLzY3K53XwlcUSMAlxVRJQoxEsmqAsQyZylqpasi5UtBySACiNURMooYphgnRylCmanxWvJ25fRuSWNacBMIVYYQQNCmuZ0UT5E700XW5YRGkE_cPIW6FjIPTrRGNRYoRCzTGhlQE8KohXLFKWYxrwGRmnS_VRtWZRhs_RNk-gj7-8e5ObMMvwQDkANAMeL8AYvg5mjSIziVt8hK9CeN931VdUViDLH33j_T_05FZpWNIKRp7aAYCMZ3eg0tMpyeW08u2N8eDHEwPt4b_AFhR2yE</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Yoon, Jung Hyun</creator><creator>Han, Kyunghwa</creator><creator>Lee, Eunjung</creator><creator>Lee, Jandee</creator><creator>Kim, Eun-Kyung</creator><creator>Moon, Hee Jung</creator><creator>Park, Vivian Youngjean</creator><creator>Nam, Kee Hyun</creator><creator>Kwak, Jin Young</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6212-1495</orcidid></search><sort><creationdate>2020</creationdate><title>Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma</title><author>Yoon, Jung Hyun ; Han, Kyunghwa ; Lee, Eunjung ; Lee, Jandee ; Kim, Eun-Kyung ; Moon, Hee Jung ; Park, Vivian Youngjean ; Nam, Kee Hyun ; Kwak, Jin Young</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3718-60a08a636ba44ea2a5d0ef72e5ffab9188bb1f8140269127a2d7b7344cbe67b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age</topic><topic>Biology and Life Sciences</topic><topic>Biomarkers</topic><topic>Cancer</topic><topic>Feature extraction</topic><topic>Hospitals</topic><topic>Lymphatic system</topic><topic>Medical diagnosis</topic><topic>Medical prognosis</topic><topic>Medical schools</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Metastasis</topic><topic>Mortality</topic><topic>Mutation</topic><topic>Papillary thyroid carcinoma</topic><topic>Patients</topic><topic>Physical Sciences</topic><topic>Radiology</topic><topic>Radiomics</topic><topic>Regression analysis</topic><topic>Regression models</topic><topic>Research and Analysis Methods</topic><topic>Statistical analysis</topic><topic>Subgroups</topic><topic>Surgery</topic><topic>Thyroid</topic><topic>Thyroid cancer</topic><topic>Training</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yoon, Jung Hyun</creatorcontrib><creatorcontrib>Han, Kyunghwa</creatorcontrib><creatorcontrib>Lee, Eunjung</creatorcontrib><creatorcontrib>Lee, Jandee</creatorcontrib><creatorcontrib>Kim, Eun-Kyung</creatorcontrib><creatorcontrib>Moon, Hee Jung</creatorcontrib><creatorcontrib>Park, Vivian Youngjean</creatorcontrib><creatorcontrib>Nam, Kee Hyun</creatorcontrib><creatorcontrib>Kwak, Jin Young</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yoon, Jung Hyun</au><au>Han, Kyunghwa</au><au>Lee, Eunjung</au><au>Lee, Jandee</au><au>Kim, Eun-Kyung</au><au>Moon, Hee Jung</au><au>Park, Vivian Youngjean</au><au>Nam, Kee Hyun</au><au>Kwak, Jin Young</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2020</date><risdate>2020</risdate><volume>15</volume><issue>2</issue><spage>e0228968</spage><epage>e0228968</epage><pages>e0228968-e0228968</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>To evaluate whether if ultrasonography (US)-based radiomics enables prediction of the presence of BRAFV600E mutations among patients diagnosed as papillary thyroid carcninoma (PTC).
From December 2015 to May 2017, 527 patients who had been treated surgically for PTC were included (training: 387, validation: 140). All patients had BRAFV600E mutation analysis performed on surgical specimen. Feature extraction was performed using preoperative US images of the 527 patients (mean size of PTC: 16.4mm±7.9, range, 10-85 mm). A Radiomics Score was generated by using the least absolute shrinkage and selection operator (LASSO) regression model. Univariable/multivariable logistic regression analysis was performed to evaluate the factors including Radiomics Score in predicting BRAFV600E mutation. Subgroup analysis including conventional PTC <20-mm (n = 389) was performed (training: 280, validation: 109).
Of the 527 patients diagnosed with PTC, 428 (81.2%) were positive and 99 (18.8%) were negative for BRAFV600E mutation. In both total 527 cancers and 389 conventional PTC<20-mm, Radiomics Score was the single factor showing significant association to the presence of BRAFV600E mutation on multivariable analysis (all P<0.05). C-statistics for the validation set in the total cancers and the conventional PTCs<20-mm were lower than that of the training set: 0.629 (95% CI: 0.516-0.742) to 0.718 (95% CI: 0.650-0.786), and 0.567 (95% CI: 0.434-0.699) to 0.729 (95% CI: 0.632-0.826), respectively.
Radiomics features extracted from US has limited value as a non-invasive biomarker for predicting the presence of BRAFV600E mutation status of PTC regardless of size.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>32053670</pmid><doi>10.1371/journal.pone.0228968</doi><orcidid>https://orcid.org/0000-0002-6212-1495</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2020, Vol.15 (2), p.e0228968-e0228968 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_2354744429 |
source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
subjects | Age Biology and Life Sciences Biomarkers Cancer Feature extraction Hospitals Lymphatic system Medical diagnosis Medical prognosis Medical schools Medicine Medicine and Health Sciences Metastasis Mortality Mutation Papillary thyroid carcinoma Patients Physical Sciences Radiology Radiomics Regression analysis Regression models Research and Analysis Methods Statistical analysis Subgroups Surgery Thyroid Thyroid cancer Training Ultrasound |
title | Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T23%3A48%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Radiomics%20in%20predicting%20mutation%20status%20for%20thyroid%20cancer:%20A%20preliminary%20study%20using%20radiomics%20features%20for%20predicting%20BRAFV600E%20mutations%20in%20papillary%20thyroid%20carcinoma&rft.jtitle=PloS%20one&rft.au=Yoon,%20Jung%20Hyun&rft.date=2020&rft.volume=15&rft.issue=2&rft.spage=e0228968&rft.epage=e0228968&rft.pages=e0228968-e0228968&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0228968&rft_dat=%3Cproquest_plos_%3E2354744429%3C/proquest_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2354744429&rft_id=info:pmid/32053670&rft_doaj_id=oai_doaj_org_article_df2b74f0c33e454085d48b75bf33907a&rfr_iscdi=true |